查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590617

大便潛血試驗市場：按產品和最終用戶 - 全球預測 2025-2030

Fecal Occult Testing Market by Product (Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Immuno-FOB ELISA Test), End-User (Clinical Diagnostic Laboratories, Hospitals, Physicians' Office & Laboratories) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年大便潛血試驗市值為1.788億美元，預計到2024年將達到1.9257億美元，複合年成長率為7.79%，到2030年將達到3.0237億美元。

大便潛血試驗（FOBT）是一種非侵入性診斷方法，主要用於檢測糞便潛血，糞便潛血是大腸直腸癌和其他胃腸道疾病的指標。 FOBT的範圍從定期健康檢查延伸到早期發現癌症，促進預防保健措施。大腸直腸癌盛行率的不斷上升推動了對 FOBT 的需求，從而推動了對易於使用且具有成本效益的篩檢解決方案的需求。應用包括家庭檢測套組和臨床環境中的使用，解決個人健康監測和公共衛生舉措。最終用途範圍從醫院和診斷實驗室到居家醫療機構，支持廣泛的潛在就業機會。

主要市場統計
基準年[2023] 1.788 億美元
預測年份 [2024] 1.9257 億美元
預測年份 [2030] 30237萬美元
複合年成長率（%） 7.79%

影響該市場的主要成長要素包括人們對大腸直腸癌的認知不斷提高、政府對癌症篩檢的支持政策以及測試敏感性和特異性的進步。此外，老年人口的成長和注重健康的消費者的激增正在推動需求。潛在的機會在於擴大人口覆蓋範圍、利用數位健康平台進行遠端監控以及與醫療保健提供者建立合作夥伴關係以進行宣傳活動。利用這些機會的建議包括提高用戶便利性、投資研發以提高準確性以及進行策略行銷以消除圍繞測試的文化偏見。

然而，其局限性包括測試結果的可變性、發展中地區缺乏認知以及來自結腸鏡檢查和乙狀結腸鏡檢查等替代診斷方法的競爭。監管障礙以及定期測試和檢驗的需要也阻礙了成長。最佳創新領域包括將人工智慧融入結果分析、開發更敏感的生物標記物以及提高偏遠地區人們的檢測可及性。 FOBT 市場的動態和競爭性質要求相關人員專注於技術進步和客戶教育，以保持市場相關性並推動業務成長。透過策略投資和創新，公司可以克服障礙並提高測試效率和採用率。

市場動態：快速發展的大便潛血試驗市場的關鍵市場洞察

供需的動態交互作用正在改變大便潛血試驗市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 直腸癌和結腸癌的盛行率增加
    • 非營利組織和政府的積極努力
    • 越來越注重綜合醫療服務，以改善病患體驗和健康結果
  • 市場限制因素
    • 大便潛血試驗產品相關的高成本
  • 市場機會
    • 對照護現場診斷 (POCD) 的偏好日益增加
    • 大便潛血試驗不斷取得進展
  • 市場挑戰
    • 嚴格的監管準則和缺乏訓練有素的專業人員

波特的五力：駕馭大便潛血試驗市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對大便潛血試驗市場的影響

外部宏觀環境因素對大便潛血試驗市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解大便潛血試驗市場的競爭狀況

大便潛血試驗市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣大便潛血試驗市場供應商績效評估

FPNV定位矩陣是評估大便潛血試驗市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃大便潛血試驗市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，大便潛血試驗市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 直腸癌和結腸癌的發生率增加
      • 非營利組織和政府的積極舉措
      • 越來越注重綜合醫療服務，以改善病患體驗和健康結果
    • 抑制因素
      • 大便潛血試驗產品相關的高成本
    • 機會
      • 照護現場診斷 (POCD) 的趨勢不斷成長
      • 大便潛血試驗不斷取得進展
    • 任務
      • 嚴格的監管準則和缺乏訓練有素的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章大便潛血試驗市場：依產品

  • 癒創木脂 FOB糞便檢驗
  • 免疫FOB凝集試驗
  • 免疫 FOB ELISA 測試
  • 側流免疫FOB測試

第7章大便潛血試驗市場：依最終用戶分類

  • 臨床診斷實驗室
  • 醫院
  • 醫生辦公室和檢查室

第8章 北美和南美大便潛血試驗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太大便潛血試驗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲大便潛血試驗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Alfa Scientific Designs, Inc.
  • Apacor Limited
  • Beckman Coulter, Inc.
  • Biohit Oyj
  • CTK Biotech, Inc.
  • EDP Biotech Corporation
  • Eiken Chemical Co., Ltd.
  • Epigenomics AG
  • Immunostics, Inc.
  • LifeSign LLC
  • Polymedco, Inc.
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Stat Technologies
Product Code: MRR-4348D129FB2A

The Fecal Occult Testing Market was valued at USD 178.80 million in 2023, expected to reach USD 192.57 million in 2024, and is projected to grow at a CAGR of 7.79%, to USD 302.37 million by 2030.

Fecal occult blood testing (FOBT) is a non-invasive diagnostic procedure primarily used to detect hidden blood in stool, which can be an indicator of colorectal cancer or other gastrointestinal disorders. The scope of FOBT extends from regular health check-ups to early cancer detection, promoting preventive healthcare measures. Its necessity stems from the increasing prevalence of colorectal cancer, propelling the demand for accessible and cost-effective screening solutions. Applications include home testing kits and use in clinical settings, catering to both individual health monitoring and public health initiatives. The end-use spectrum ranges from hospitals and diagnostic laboratories to home healthcare agencies, underpinning a versatile adoption potential.

KEY MARKET STATISTICS
Base Year [2023] USD 178.80 million
Estimated Year [2024] USD 192.57 million
Forecast Year [2030] USD 302.37 million
CAGR (%) 7.79%

Key growth factors influencing this market include the rising awareness about colorectal cancer, supportive government policies for cancer screening, and advancements in test sensitivity and specificity. Additionally, the increasing geriatric population, coupled with a surge in health-conscious consumers, fuels demand. Potential opportunities lie in expanding the demographic reach, leveraging digital health platforms for remote monitoring, and fostering collaborations with healthcare providers for awareness campaigns. Recommendations to capitalize on these opportunities include enhancing user convenience, investing in R&D for improved accuracy, and strategic marketing to break cultural stigmas around testing.

However, limitations such as variations in test results, lack of awareness in developing regions, and competition from alternative diagnostic methods like colonoscopy and sigmoidoscopy pose challenges. Regulatory hurdles and the need for periodic test validation can also impede growth. The best areas for innovation involve integrating AI in result analysis, developing more sensitive biomarkers, and improving test accessibility for remote populations. The nature of the FOBT market is dynamic and competitive, requiring stakeholders to focus on technological advancements and customer education to maintain market relevance and drive business growth. With strategic investments and innovation, companies can overcome obstacles and enhance the test's efficacy and adoption.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fecal Occult Testing Market

The Fecal Occult Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of rectal & colon cancer
    • Favorable initiatives by non-profit organizations and governments
    • Rising focus on integrated health services for improved patient experience and health outcomes
  • Market Restraints
    • High cost associated with fecal occult blood test products
  • Market Opportunities
    • Increasing inclination towards point-of-care diagnostics (POCD)
    • Ongoing advances in fecal occult blood tests
  • Market Challenges
    • Stringent regulatory guidelines and dearth of trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Fecal Occult Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fecal Occult Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fecal Occult Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fecal Occult Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fecal Occult Testing Market

A detailed market share analysis in the Fecal Occult Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fecal Occult Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fecal Occult Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fecal Occult Testing Market

A strategic analysis of the Fecal Occult Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fecal Occult Testing Market, highlighting leading vendors and their innovative profiles. These include Alfa Scientific Designs, Inc., Apacor Limited, Beckman Coulter, Inc., Biohit Oyj, CTK Biotech, Inc., EDP Biotech Corporation, Eiken Chemical Co., Ltd., Epigenomics AG, Immunostics, Inc., LifeSign LLC, Polymedco, Inc., Quest Diagnostics Incorporated, Quidel Corporation, Randox Laboratories Ltd., and Stat Technologies.

Market Segmentation & Coverage

This research report categorizes the Fecal Occult Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Immuno-FOB ELISA Test, and Lateral Flow Immuno-FOB Test.
  • Based on End-User, market is studied across Clinical Diagnostic Laboratories, Hospitals, and Physicians' Office & Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of rectal & colon cancer
      • 5.1.1.2. Favorable initiatives by non-profit organizations and governments
      • 5.1.1.3. Rising focus on integrated health services for improved patient experience and health outcomes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with fecal occult blood test products
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing inclination towards point-of-care diagnostics (POCD)
      • 5.1.3.2. Ongoing advances in fecal occult blood tests
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory guidelines and dearth of trained professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fecal Occult Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Guaiac FOB Stool Test
  • 6.3. Immuno-FOB Agglutination Test
  • 6.4. Immuno-FOB ELISA Test
  • 6.5. Lateral Flow Immuno-FOB Test

7. Fecal Occult Testing Market, by End-User

  • 7.1. Introduction
  • 7.2. Clinical Diagnostic Laboratories
  • 7.3. Hospitals
  • 7.4. Physicians' Office & Laboratories

8. Americas Fecal Occult Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Fecal Occult Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Fecal Occult Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alfa Scientific Designs, Inc.
  • 2. Apacor Limited
  • 3. Beckman Coulter, Inc.
  • 4. Biohit Oyj
  • 5. CTK Biotech, Inc.
  • 6. EDP Biotech Corporation
  • 7. Eiken Chemical Co., Ltd.
  • 8. Epigenomics AG
  • 9. Immunostics, Inc.
  • 10. LifeSign LLC
  • 11. Polymedco, Inc.
  • 12. Quest Diagnostics Incorporated
  • 13. Quidel Corporation
  • 14. Randox Laboratories Ltd.
  • 15. Stat Technologies

LIST OF FIGURES

  • FIGURE 1. FECAL OCCULT TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. FECAL OCCULT TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FECAL OCCULT TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. FECAL OCCULT TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. FECAL OCCULT TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FECAL OCCULT TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FECAL OCCULT TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FECAL OCCULT TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY GUAIAC FOB STOOL TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY IMMUNO-FOB AGGLUTINATION TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY IMMUNO-FOB ELISA TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY LATERAL FLOW IMMUNO-FOB TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FECAL OCCULT TESTING MARKET SIZE, BY PHYSICIANS' OFFICE & LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES FECAL OCCULT TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA FECAL OCCULT TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM FECAL OCCULT TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. FECAL OCCULT TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. FECAL OCCULT TESTING MARKET, FPNV POSITIONING MATRIX, 2023